Denali Therapeutics Inc. (DNLI) Misses Q1 EPS by 3c

Denali Therapeutics Inc. (NASDAQ: DNLI) reported Q1 EPS of ($0.69), $0.03 worse than the analyst estimate of ($0.66).

For earnings history and earnings-related data on Denali Therapeutics Inc. (DNLI) click here.

You May Also Be Interested In

• Movano (MOVE) Misses Q2 EPS by 195c
• JD.com (JD) Reiterated at Buy by Benchmark Amid Earnings Recovery
• Full Circle Lithium closes $5.14M private placement